TG Therapeutics
TGTX
TGTX
371 hedge funds and large institutions have $3.88B invested in TG Therapeutics in 2025 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 118 increasing their positions, 115 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
13% more funds holding
Funds holding: 327 → 371 (+44)
3% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 115
0.42% more ownership
Funds ownership: 62.23% → 62.65% (+0.42%)
Holders
371
Holding in Top 10
7
Calls
$118M
Puts
$96.4M
Top Buyers
| 1 | +$45.3M | |
| 2 | +$31.9M | |
| 3 | +$30.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.1M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$21M |
Top Sellers
| 1 | -$69.6M | |
| 2 | -$68M | |
| 3 | -$18M | |
| 4 |
BlackRock
New York
|
-$15.9M |
| 5 |
6CM
683 Capital Management
New York
|
-$15.9M |
